Observing eye disease progression in type 2 diabetes
Part of Eyes & vision, Heart & circulation, Hormones & metabolism clinical trials.
This study closely follows people with type 2 diabetes who have early signs of diabetic retinopathy (damage to the retina from diabetes) to see how the condition changes over time. It does not test a new treatment but monitors the eye's health closely. It may be a good fit if you have diabetic retinopathy that does not need immediate treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes, as defined by standard medical criteria.
- You are between 35 and 80 years old.
- Your vision is good (equivalent to at least 20/40 with glasses or contacts).
- You have a specific, early stage of diabetic retinopathy that does not need immediate laser or injection therapy.
- You have not had prior laser treatment (panretinal photocoagulation) or injections in the eye for retinopathy.
- You have not had eye surgery in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks back at medical records of people with type 2 diabetes to understand how diabetic eye disease (retinopathy) progresses and when treatment is needed. It may help doctors better predict risks and guide future care.
This study tests whether advanced eye imaging can predict how diabetic eye disease (retinopathy) may worsen over time. If you have type 2 diabetes and early to moderate diabetic retinopathy without swelling in the central part of the retina, you may be able to join.
This study looks at early damage to the retina (the back of the eye) in people with type 2 diabetes, even before vision problems start. It aims to find new ways to detect and treat diabetic eye disease early.
This study is testing a better way to diagnose and manage eye problems (diabetic retinopathy) in people with type 2 diabetes. It aims to improve how doctors find and treat these issues to help protect your vision.
This program aims to screen people for diabetic eye problems early and help prevent vision loss over time. It may help you if you have type 2 diabetes (or you’ve been invited as a diabetes/non-diabetes participant) and can safely take part in the study activities.
This study looks for specific eye findings (“biomarkers”) in people with type 2 diabetes using eye imaging. It may help researchers better understand diabetic retinopathy and how to detect it earlier or more accurately.
Hear when a new Diabetic Retinopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.